Sulforaphane alleviates scopolamine-induced memory impairment in mice

Pharmacological Research

Volumn 85, Issue , 2014, Pages 23-32

  Lee, Siyoung ^a   Kim, Jisung ^a   Seo, Sang Gwon ^a,d   Choi, Bo Ryoung ^b   Han, Jung Soo ^b   Lee, Ki Won ^a,c,d,e   Kim, Jiyoung ^c,e  

^a Seoul National University   (South Korea)

^b Konkuk University   (South Korea)

^c Seoul National University   (South Korea)

^d Seoul National University   (South Korea)

^e Seoul National University   (South Korea)

Author keywords

Acetylcholine; Acetylcholinesterase; Choline acetyltransferase; Memory; Sulforaphane

Indexed keywords

ACETYLCHOLINE; ACETYLCHOLINESTERASE; CHOLINE ACETYLTRANSFERASE; SCOPOLAMINE; SULFORAPHANE; ISOTHIOCYANIC ACID DERIVATIVE; NEUROPROTECTIVE AGENT; SCOPOLAMINE BROMIDE; SULFORAFAN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CELL; CHOLINERGIC SYSTEM; COGNITION; CONTROLLED STUDY; EMBRYO; ENZYME ACTIVITY; FEMALE; FRONTAL CORTEX; HIPPOCAMPUS; IN VITRO STUDY; LEARNING DISORDER; MEMORY CONSOLIDATION; MEMORY DISORDER; MORRIS WATER MAZE TEST; MOUSE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; ANIMAL; C57BL MOUSE; CELL CULTURE; CHEMICALLY INDUCED; DRUG EFFECTS; FRONTAL LOBE; INSTITUTE FOR CANCER RESEARCH MOUSE; MAZE TEST; MEMORY DISORDERS; METABOLISM; NERVE CELL;

ACETYLCHOLINE; ACETYLCHOLINESTERASE; ANIMALS; CELLS, CULTURED; CHOLINE O-ACETYLTRANSFERASE; FEMALE; FRONTAL LOBE; HIPPOCAMPUS; ISOTHIOCYANATES; MAZE LEARNING; MEMORY DISORDERS; MICE, INBRED C57BL; MICE, INBRED ICR; NEURONS; NEUROPROTECTIVE AGENTS; SCOPOLAMINE HYDROBROMIDE;

EID: 84902532816     PISSN: 10436618     EISSN: 10961186     Source Type: Journal    
DOI: 10.1016/j.phrs.2014.05.003     Document Type: Article

References (38)

1. Y. Zhang, J. Li, and L. Tang Cancer-preventive isothiocyanates: dichotomous modulators of oxidative stress Free Radic Biol Med 38 2005 70 77
2. A.T. Dinkova-Kostova, and R.V. Kostov Glucosinolates and isothiocyanates in health and disease Trends Mol Med 18 2012 337 347
3. D. Vauzour, M. Buonfiglio, G. Corona, J. Chirafisi, K. Vafeiadou, and C. Angeloni et al. Sulforaphane protects cortical neurons against 5-S-cysteinyl-dopamine-induced toxicity through the activation of ERK1/2, Nrf-2 and the upregulation of detoxification enzymes Mol Nutr Food Res 54 2010 532 542
4. H.M. Park, J.A. Kim, and M.K. Kwak Protection against amyloid beta cytotoxicity by sulforaphane: role of the proteasome Arch Pharm Res 32 2009 109 115
5. J. Zhao, N. Kobori, J. Aronowski, and P.K. Dash Sulforaphane reduces infarct volume following focal cerebral ischemia in rodents Neurosci Lett 393 2006 108 112
6. J. Zhao, A.N. Moore, G.L. Clifton, and P.K. Dash Sulforaphane enhances aquaporin-4 expression and decreases cerebral edema following traumatic brain injury J Neurosci Res 82 2005 499 506
7. J.K. Blusztajn, and R.J. Wurtman Choline and cholinergic neurons Science 221 1983 614 620
8. E.P. Brandon, T. Mellott, D.P. Pizzo, N. Coufal, K.A. D'Amour, and K. Gobeske et al. Choline transporter 1 maintains cholinergic function in choline acetyltransferase haploinsufficiency J Neurosci 24 2004 5459 5466
9. P. Mohapel, G. Leanza, M. Kokaia, and O. Lindvall Forebrain acetylcholine regulates adult hippocampal neurogenesis and learning Neurobiol Aging 26 2005 939 946
10. R.T. Bartus, R.L. Dean 3rd, B. Beer, and A.S. Lippa The cholinergic hypothesis of geriatric memory dysfunction Science 217 1982 408 414
11. H. Eichenbaum How does the brain organize memories? Science 277 1997 330 332
12. E. Giacobini Cholinesterase inhibitors: new roles and therapeutic alternatives Pharmacol Res 50 2004 433 440
13. Y. Oda Choline acetyltransferase: the structure, distribution and pathologic changes in the central nervous system Pathol Int 49 1999 921 937
14. A. Zambrzycka, M. Alberghina, and J.B. Strosznajder Effects of aging and amyloid-beta peptides on choline acetyltransferase activity in rat brain Neurochem Res 27 2002 277 281
15. G.R. Dawson, C.M. Heyes, and S.D. Iversen Pharmacological mechanisms and animal models of cognition Behav Pharmacol 3 1992 285 297
16. S.E. Molchan, R.A. Martinez, J.L. Hill, H.J. Weingartner, K. Thompson, and B. Vitiello et al. Increased cognitive sensitivity to scopolamine with age and a perspective on the scopolamine model Brain Res Brain Res Rev 17 1992 215 226
17. S.D. Iversen Behavioural evaluation of cholinergic drugs Life Sci 60 1997 1145 1152
18. E. Abe Reversal effect of DM-9384 on scopolamine-induced acetylcholine depletion in certain regions of the mouse brain Psychopharmacology 105 1991 310 316
19. J. Ray, D.A. Peterson, M. Schinstine, and F.H. Gage Proliferation, differentiation, and long-term culture of primary hippocampal neurons Proc Natl Acad Sci USA 90 1993 3602 3606
20. M.G. Giovannini, G. Spignoli, V. Carla, and G. Pepeu A decrease in brain catecholamines prevents oxiracetam antagonism of the effects of scopolamine on memory and brain acetylcholine Pharmacol Res 24 1991 395 405
21. S. Hirokawa, M. Nose, A. Ishige, S. Amagaya, T. Oyama, and Y. Ogihara Effect of Hachimi-jio-gan on scopolamine-induced memory impairment and on acetylcholine content in rat brain J Ethnopharmacol 50 1996 77 84
22. G. Pepeu, and M.G. Giovannini Changes in acetylcholine extracellular levels during cognitive processes Learn Mem 11 2004 21 27
23. J. Hartmann, C. Kiewert, E.G. Duysen, O. Lockridge, and J. Klein Choline availability and acetylcholine synthesis in the hippocampus of acetylcholinesterase-deficient mice Neurochem Int 52 2008 972 978
24. Z. Dong, and A. Fu Prevention of age-related memory deficit in transgenic mice by human choline acetyltransferase Eur J Pharmacol 683 2012 174 178
25. A.L. Fu, S.J. Huang, and M.J. Sun Complementary remedy of aged-related learning and memory deficits via exogenous choline acetyltransferase Biochem Biophys Res Commun 336 2005 268 273
26. A.V. Terry Jr., and J.J. Buccafusco The cholinergic hypothesis of age and Alzheimer's disease-related cognitive deficits: recent challenges and their implications for novel drug development J Pharmacol Exp Ther 306 2003 821 827
27. L. Huang, T. Su, and X. Li Natural products as sources of new lead compounds for the treatment of Alzheimer's disease Curr Top Med Chem 13 2013 1864 1878
28. T. Yamamori, K. Fukada, R. Aebersold, S. Korsching, M.J. Fann, and P.H. Patterson The cholinergic neuronal differentiation factor from heart cells is identical to leukemia inhibitory factor Science 246 1989 1412 1416
29. J.A. Johnson, and N.M. Nathanson Differential requirements for p21ras and protein kinase C in the regulation of neuronal gene expression by nerve growth factor and neurokines J Biol Chem 269 1994 18856 18863
30. S. Saadat, M. Sendtner, and H. Rohrer Ciliary neurotrophic factor induces cholinergic differentiation of rat sympathetic neurons in culture J Cell Biol 108 1989 1807 1816
31. A. Burgess, and I. Aubert Polysialic acid limits choline acetyltransferase activity induced by brain-derived neurotrophic factor J Neurochem 99 2006 797 806
32. N. Kitiyanant, Y. Kitiyanant, C.N. Svendsen, and W. Thangnipon BDNF-, IGF-1- and GDNF-secreting human neural progenitor cells rescue amyloid beta-induced toxicity in cultured rat septal neurons Neurochem Res 37 2012 143 152
33. P.K. Dash, J. Zhao, S.A. Orsi, M. Zhang, and A.N. Moore Sulforaphane improves cognitive function administered following traumatic brain injury Neurosci Lett 460 2009 103 107
34. H.V. Kim, H.Y. Kim, H.Y. Ehrlich, S.Y. Choi, D.J. Kim, and Y. Kim Amelioration of Alzheimer's disease by neuroprotective effect of sulforaphane in animal model Amyloid 20 2013 7 12
35. F. Morroni, A. Tarozzi, G. Sita, C. Bolondi, J.M. Zolezzi Moraga, and G. Cantelli-Forti et al. Neuroprotective effect of sulforaphane in 6-hydroxydopamine-lesioned mouse model of Parkinson's disease Neurotoxicology 36 2013 63 71
36. A.V. Gasper, A. Al-Janobi, J.A. Smith, J.R. Bacon, P. Fortun, and C. Atherton et al. Glutathione S-transferase M1 polymorphism and metabolism of sulforaphane from standard and high-glucosinolate broccoli Am J Clin Nutr 82 2005 1283 1291
37. R. Hu, V. Hebbar, B.R. Kim, C. Chen, B. Winnik, and B. Buckley et al. In vivo pharmacokinetics and regulation of gene expression profiles by isothiocyanate sulforaphane in the rat J Pharmacol Exp Ther 310 2004 263 271
38. W.M. Pardridge Blood-brain barrier delivery Drug Discov Today 12 2007 54 61